Affinity Asset Advisors, LLC Glycomimetics Inc Transaction History
Affinity Asset Advisors, LLC
- $896 Million
- Q1 2025
A detailed history of Affinity Asset Advisors, LLC transactions in Glycomimetics Inc stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 142,300 shares of GLYC stock, worth $2.3 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
142,300Holding current value
$2.3 Million% of portfolio
0.06%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding GLYC
# of Institutions
38Shares Held
30.8MCall Options Held
80.9KPut Options Held
20.8K-
Bvf Inc San Francisco, CA9.54MShares$154 Million0.09% of portfolio
-
Logos Global Management LP San Francisco, CA5.4MShares$87.2 Million0.22% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.09MShares$82.2 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY3MShares$48.4 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$43.1 Million0.0% of portfolio
About GLYCOMIMETICS INC
- Ticker GLYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,423,900
- Market Cap $847M
- Description
- GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...